bims-cytox1 Biomed news
on Cytochrome oxidase subunit 1
Issue of 2018‒10‒07
one paper selected by
Gavin McStay
Staffordshire University


  1. Am J Pathol. 2018 Sep 27. pii: S0002-9440(18)30225-6. [Epub ahead of print]
    Baek JH, Gomez IG, Wada Y, Roach A, Mahad D, Duffield JS.
      Mutations in mitochondrial DNA as well as nuclear-encoded mitochondrial proteins have been reported to cause tubulointerstitial kidney diseases and focal segmental glomerulosclerosis (FSGS). Recently, genes and pathways affecting mitochondrial turnover and permeability have been implicated in adult-onset FSGS. Furthermore, dysfunctioning mitochondria may be capable of engaging intracellular innate immune sensing pathways. To determine the impact of mitochondrial dysfunction in FSGS and secondary innate immune responses, we generated Cre/loxP transgenic mice to create loss-of-function deletion mutation of the Complex IV assembly co-factor heme A:farnesyltransferase (COX10) restricted to cells of the developing nephrons. These mice develop severe, early onset FSGS with innate immune activation and die prematurely with kidney failure. Mutant kidneys showed loss of glomerular and tubular epithelial function, epithelial apoptosis and, in addition, a marked interferon response. In vitro modeling of Cox10 deletion in primary kidney epithelium compromises oxygen consumption, ATP generation, and induces oxidative stress. In addition, loss of Cox10 triggers a selective interferon response, which may be caused by the leak of mitochondrial DNA into the cytosol activating the intracellular DNA sensor, STING. This new animal model provides a mechanism to study mitochondrial dysfunction in vivo and demonstrates a direct link between mitochondrial dysfunction and intracellular innate immune response.
    DOI:  https://doi.org/10.1016/j.ajpath.2018.08.018